Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · IEX Real-Time Price · USD
4.580
+0.040 (0.88%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $49.28 million as of July 26, 2024. Its market cap has decreased by -12.32% in one year.
Market Cap
49.28M
Enterprise Value
11.11M
1-Year Change
-12.32%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $90.20M to $49.28M, a decrease of -45.37%. That is a compound annual growth rate of -13.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 48.80M | 4.95% |
| Dec 29, 2023 | 46.50M | -29.12% |
| Dec 30, 2022 | 65.60M | -26.54% |
| Dec 31, 2021 | 89.30M | -25.40% |
| Dec 31, 2020 | 119.70M | 32.71% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reneo Pharmaceuticals | 49.80M |
| Modular Medical | 49.78M |
| NeueHealth | 49.43M |
| Lexaria Bioscience | 48.85M |
| Apyx Medical | 48.85M |
| Bionano Genomics | 48.61M |
| Kezar Life Sciences | 47.93M |
| Atara Biotherapeutics | 47.87M |